Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pradefovir mesylate (Hepavir B) is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with Km of 60 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 213.00 | |
5 mg | In stock | $ 455.00 | |
10 mg | In stock | $ 672.00 | |
25 mg | In stock | $ 1,060.00 | |
50 mg | In stock | $ 1,430.00 | |
100 mg | In stock | $ 1,920.00 |
Description | Pradefovir mesylate (Hepavir B) is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with Km of 60 μM. |
Targets&IC50 | CYP3A4:60 μM(Km,liver) |
In vitro | Pradefovir was converted to PMEA in human liver microsomes with a K(m) of 60 microM, a maximum rate of metabolism of 228 pmol/min/mg protein, and an intrinsic clearance of about 359 ml/min.?Addition of ketoconazole and monoclonal antibody 3A4 significantly inhibits the conversion of pradefovir to PMEA in human liver microsomes, suggesting the predominant role of CYP3A4 in the metabolic activation of pradefovir.?Pradefovir at 0.2, 2, and 20 microM was neither a direct inhibitor nor a mechanism-based inhibitor of CYP3A4, CYP2D6, CYP2C9, CYP2C19, CYP2E1, and CYP1A2 in human liver microsomes. |
In vivo | In rats, the liver was the site of metabolic activation of pradefovir, whereas the small intestine did not play a significant role in the metabolic conversion of pradefovir to PMEA.?Daily oral dosing (300 mg/kg) to rats for 8 days showed that pradefovir was not an inducer of P450 enzymes in rats[1].? |
Synonyms | Pradefovir mesilate, Remofovir mesylate, Hepavir B |
Molecular Weight | 519.9 |
Formula | C18H23ClN5O7PS |
CAS No. | 625095-61-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 120 mg/mL (230.81 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pradefovir mesylate 625095-61-6 Metabolism P450 Pradefovir Cytochrome P450 Remofovir Mesylate Pradefovir mesilate Remofovir mesylate CYPs Inhibitor Hepavir B Pradefovir Mesylate Remofovir inhibit inhibitor